Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients
Status:
Terminated
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This is a non-interventional study to review safety data on administration of desvenlafaxine
succinate among Filipino patients with MDD and VMS per usual clinical practice within the
first three years post commercial distribution.